Valuation (41%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 28.78 | 100.43 |
| PEG Ratio (TTM) | -8.64 | -1.21 |
| P/S Ratio (TTM) | 1.74 | 1.95 |
| P/B Ratio (TTM) | 1.18 | 2.01 |
| P/FCF Ratio (TTM) | 15.44 | 17.02 |
| Price to 5YR AVG Earnings Ratio | -44.21 | 18.74 |
| Price to 5YR AVG FCF Ratio | -63.01 | 15.58 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.13% | 2.96% |
| ROE (TTM) | 4.13% | 9.69% |
| Net Profit Margin (TTM) | 6.08% | 8.26% |
| ROIC 5YR AVG | 2.15% | 1.63% |
Growth (48%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 23.93% | -50.23% | -4.60% |
| Revenue | 1.35% | 9.97% | 22.76% |
| Net Income | 32.88% | -52.05% | -4.25% |
| Cash Flow | 5.87% | -19.31% | 1,799.40% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.92 | 2.27 |
| Quick Ratio (TTM) | 0.92 | 2.27 |
| D/E Ratio (TTM) | 0.67 | 1.23 |
| Interest Coverage (TTM) | -0.79 | 2.07 |
| Piotroski F-Score | 8 | 7 |
| Altman Z-Score | 0.97 | 1.44 |
| LTL to 5YR AVG FCF | -42.00 | 13.75 |
| Shares Outstanding Growth 5YR AVG | 0.61% | 2.92% |